| UniProt ID | BNIP2_HUMAN | |
|---|---|---|
| UniProt AC | Q12982 | |
| Protein Name | BCL2/adenovirus E1B 19 kDa protein-interacting protein 2 | |
| Gene Name | BNIP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 314 | |
| Subcellular Localization | Cytoplasm. Cytoplasm, perinuclear region. Localizes to the nuclear envelope region and to other cytoplasmic structures. | |
| Protein Description | Implicated in the suppression of cell death. Interacts with the BCL-2 and adenovirus E1B 19 kDa proteins.. | |
| Protein Sequence | MEGVELKEEWQDEDFPIPLPEDDSIEADILAITGPEDQPGSLEVNGNKVRKKLMAPDISLTLDPSDGSVLSDDLDESGEIDLDGLDTPSENSNEFEWEDDLPKPKTTEVIRKGSITEYTAAEEKEDGRRWRMFRIGEQDHRVDMKAIEPYKKVISHGGYYGDGLNAIVVFAVCFMPESSQPNYRYLMDNLFKYVIGTLELLVAENYMIVYLNGATTRRKMPSLGWLRKCYQQIDRRLRKNLKSLIIVHPSWFIRTLLAVTRPFISSKFSQKIRYVFNLAELAELVPMEYVGIPECIKQVDQELNGKQDEPKNEQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 41 | Phosphorylation | GPEDQPGSLEVNGNK CCCCCCCCEEECCHH | 28.21 | 24275569 | |
| 47 (in isoform 2) | Phosphorylation | - | 34.15 | 22210691 | |
| 59 | Phosphorylation | KLMAPDISLTLDPSD EEECCCEEEEECCCC | 23.76 | 22468782 | |
| 65 | Phosphorylation | ISLTLDPSDGSVLSD EEEEECCCCCCCCCC | 55.03 | 22468782 | |
| 71 | Phosphorylation | PSDGSVLSDDLDESG CCCCCCCCCCCCCCC | 27.24 | 22468782 | |
| 77 | Phosphorylation | LSDDLDESGEIDLDG CCCCCCCCCCCCCCC | 41.20 | 24275569 | |
| 85 | Phosphorylation | GEIDLDGLDTPSENS CCCCCCCCCCCCCCC | 7.09 | 24719451 | |
| 87 | Phosphorylation | IDLDGLDTPSENSNE CCCCCCCCCCCCCCC | 33.48 | 24275569 | |
| 89 | Phosphorylation | LDGLDTPSENSNEFE CCCCCCCCCCCCCCC | 52.05 | 24275569 | |
| 92 | Phosphorylation | LDTPSENSNEFEWED CCCCCCCCCCCCCCC | 33.41 | 24275569 | |
| 101 | Phosphorylation | EFEWEDDLPKPKTTE CCCCCCCCCCCCCCE | 10.19 | 27251275 | |
| 106 | Phosphorylation | DDLPKPKTTEVIRKG CCCCCCCCCEEEECC | 36.39 | 26074081 | |
| 107 | Phosphorylation | DLPKPKTTEVIRKGS CCCCCCCCEEEECCC | 34.09 | 26074081 | |
| 109 | Phosphorylation | PKPKTTEVIRKGSIT CCCCCCEEEECCCCC | 4.88 | 27642862 | |
| 114 | Phosphorylation | TEVIRKGSITEYTAA CEEEECCCCCEEEEE | 29.40 | 29255136 | |
| 116 | Phosphorylation | VIRKGSITEYTAAEE EEECCCCCEEEEEEE | 25.33 | 22167270 | |
| 118 | Phosphorylation | RKGSITEYTAAEEKE ECCCCCEEEEEEECC | 7.95 | 30278072 | |
| 119 | Phosphorylation | KGSITEYTAAEEKED CCCCCEEEEEEECCC | 17.10 | 23927012 | |
| 145 | Ubiquitination | QDHRVDMKAIEPYKK CCCCCCHHHCCCCCC | 41.57 | - | |
| 162 | Phosphorylation | SHGGYYGDGLNAIVV HCCCCCCCCHHHEEE | 42.14 | - | |
| 174 (in isoform 2) | Ubiquitination | - | 8.01 | - | |
| 185 | Phosphorylation | SSQPNYRYLMDNLFK CCCCCHHHHHHHHHH | 8.95 | 24667141 | |
| 186 (in isoform 2) | Ubiquitination | - | 2.28 | - | |
| 198 | Phosphorylation | FKYVIGTLELLVAEN HHHHHHHHHHHHCCC | 3.53 | - | |
| 207 (in isoform 2) | Ubiquitination | - | 2.23 | - | |
| 208 | Phosphorylation | LVAENYMIVYLNGAT HHCCCEEEEEECCCC | 0.99 | - | |
| 210 | Phosphorylation | AENYMIVYLNGATTR CCCEEEEEECCCCCC | 5.41 | - | |
| 213 | Phosphorylation | YMIVYLNGATTRRKM EEEEEECCCCCCCCC | 23.00 | - | |
| 214 (in isoform 2) | Ubiquitination | - | 12.53 | - | |
| 228 | Ubiquitination | PSLGWLRKCYQQIDR CCHHHHHHHHHHHHH | 34.81 | - | |
| 230 | Phosphorylation | LGWLRKCYQQIDRRL HHHHHHHHHHHHHHH | 13.39 | - | |
| 233 | Ubiquitination | LRKCYQQIDRRLRKN HHHHHHHHHHHHHHH | 2.34 | - | |
| 235 | Phosphorylation | KCYQQIDRRLRKNLK HHHHHHHHHHHHHHH | 40.96 | 20166139 | |
| 237 | Phosphorylation | YQQIDRRLRKNLKSL HHHHHHHHHHHHHHE | 10.74 | 18088087 | |
| 239 | Phosphorylation | QIDRRLRKNLKSLII HHHHHHHHHHHHEEE | 71.82 | 27642862 | |
| 240 | Phosphorylation | IDRRLRKNLKSLIIV HHHHHHHHHHHEEEE | 46.39 | 19651622 | |
| 245 | Ubiquitination | RKNLKSLIIVHPSWF HHHHHHEEEECHHHH | 3.89 | - | |
| 266 | Ubiquitination | VTRPFISSKFSQKIR HHHHHHCHHHHHHHH | 32.67 | - | |
| 267 | Ubiquitination | TRPFISSKFSQKIRY HHHHHCHHHHHHHHH | 42.09 | 21890473 | |
| 281 (in isoform 2) | Ubiquitination | - | 3.59 | - | |
| 290 (in isoform 2) | Ubiquitination | - | 3.41 | - | |
| 306 | Phosphorylation | VDQELNGKQDEPKNE HHHHHCCCCCCCCCC | 54.20 | - | |
| 329 | Ubiquitination | ---------------------- ---------------------- | 21890473 | ||
| 329 (in isoform 2) | Ubiquitination | - | - | ||
| 333 (in isoform 2) | Ubiquitination | - | - | ||
| 340 | Ubiquitination | --------------------------------- --------------------------------- | - | ||
| 349 | Ubiquitination | ------------------------------------------ ------------------------------------------ | - | ||
| 368 (in isoform 2) | Ubiquitination | - | - | ||
| 388 | Ubiquitination | --------------------------------------------------------------------------------- --------------------------------------------------------------------------------- | - | ||
| 427 | Ubiquitination | ------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------ | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BNIP2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BNIP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BNIP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BCL2_HUMAN | BCL2 | physical | 12901880 | |
| CREB3_HUMAN | CREB3 | physical | 16189514 | |
| CDC42_HUMAN | CDC42 | physical | 10799524 | |
| BNIP2_HUMAN | BNIP2 | physical | 10954711 | |
| CDC42_HUMAN | CDC42 | physical | 10954711 | |
| RHG01_HUMAN | ARHGAP1 | physical | 10954711 | |
| RHG01_HUMAN | ARHGAP1 | physical | 10551883 | |
| FRK_HUMAN | FRK | physical | 25416956 | |
| KLC1_HUMAN | KLC1 | physical | 25416956 | |
| MYO5B_HUMAN | MYO5B | physical | 25416956 | |
| UPK1B_HUMAN | UPK1B | physical | 25416956 | |
| FATE1_HUMAN | FATE1 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY. | |
| "Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114 AND THR-116, ANDMASS SPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114, AND MASSSPECTROMETRY. | |